Physician profile
Beth Ann Holmes
NPI 1376544221
$4,287.78
in general payments reported to CMS, 2019-2025
36 companies · $688 in 2025
The $688 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $502 · 2021: $1,272 · 2022: $176 · 2023: $410 · 2024: $327 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $404.27 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $401.58 | 2019-2022 | |
| Pfizer INC. | $377.94 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.29 | 2019-2025 | Jardiance |
| Abbvie INC. | $345.78 | 2021-2025 | |
| Novo Nordisk INC | $273.69 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $259.76 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $241.42 | 2019-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $232.30 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Biohaven Pharmaceuticals, INC. | $216.36 | 2021 | |
| Radius Health, INC. | $113.47 | 2024-2025 | Tymlos |
| Merck Sharp & Dohme LLC | $101.65 | 2019-2021 | |
| Esperion Therapeutics, INC. | $95.89 | 2022-2025 | Nexletol |
| Astellas Pharma US INC | $91.41 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.32 | 2020-2021 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.